SI
GILD icon

Sentry Investments’s Gilead Sciences GILD Stock Holding History

Sentry Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$25M Sell
332,195
-436,414
-57% -$34.7M 0.37% 70
2017
Q4 		$55.1M Sell
768,609
-166,791
-18% -$12.7M 0.7% 46
2017
Q3 		$75.8M Sell
935,400
-950,000
-50% -$72.6M 0.77% 39
2017
Q2 		$133M Buy
1,885,400
+96,700
+5% +$6.43M 0.97% 24
2017
Q1 		$121M Buy
1,788,700
+58,400
+3% +$4.11M 0.84% 26
2016
Q4 		$124M Buy
1,730,300
+245,100
+17% +$18.2M 0.94% 23
2016
Q3 		$118K Buy
1,485,200
+782,500
+111% +$63.6M 0.99% 26
2016
Q2 		$58.6K Buy
702,700
+509,900
+264% +$45.3M 0.55% 43
2016
Q1 		$17.7K Buy
+192,800
New +$17.4M 0.21% 77

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sentry Investments's GILD Position: Q1 2018 in Review

Sentry Investments reduced its Gilead Sciences (GILD) stake by 57% in Q1 2018, selling an estimated $34.7M and leaving 332,195 shares worth $25M. The position accounts for 0.37% of the portfolio, ranked #70.

Sentry Investments first reported a position in GILD in Q1 2016 and has held it in 9 quarters since. The position peaked at $133M in Q2 2017. 1,563 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

  • Sentry Investments held 332,195 shares of Gilead Sciences worth $25M as of Q1 2018.
  • Sentry Investments sold 436,414 Gilead Sciences shares in Q1 2018, an estimated $34.7M.
  • Gilead Sciences made up 0.37% of Sentry Investments's portfolio in Q1 2018, its #70 holding.
  • Sentry Investments first reported a position in Gilead Sciences in Q1 2016 and has held it in 9 quarters since.
  • Sentry Investments's Gilead Sciences position peaked at $133M in Q2 2017.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on Sentry Investments's 13F filing for Q1 2018, filed 11 May 2018.